Focus Drugs Research Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.40 M
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 97.00 K
About Focus Drugs Research Laboratories
Focus Drugs Research Laboratories Private Limited (FDRLPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 September 1995 and has a history of 29 years and four months. Its registered office is in Kasargod, Kerala, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.40 M.
The company currently has active open charges totaling ₹97,000.00.
Rajeevan Anandoth, Hussainar Rahman, Eruvate Nair, and Two other members serve as directors at the Company.
Company Details
-
Location
Kasargod, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100KL1995PTC009454
-
Company No.
009454
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Sep 1995
-
Date of AGM
30 Sep 2010
-
Date of Balance Sheet
31 Mar 2010
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Focus Drugs Research Laboratories?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeevan Anandoth
|
Director | 30-Sep-2003 | Current |
|
Hussainar Rahman
|
Director | 30-Sep-2003 | Current |
|
Eruvate Nair
|
Director | 30-Sep-2003 | Current |
|
Melangot Vijayan
|
Director | 30-Sep-2003 | Current |
|
Sreekumar Vannarath
|
Director | 29-Sep-2007 | Current |
Financial Performance of Focus Drugs Research Laboratories.
Enhance accessibility to Focus Drugs Research Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Focus Drugs Research Laboratories?
Unlock access to Focus Drugs Research Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.10 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2000 | Canara Bank | ₹0.10 M | Open |
How Many Employees Work at Focus Drugs Research Laboratories?
Unlock and access historical data on people associated with Focus Drugs Research Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Focus Drugs Research Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Focus Drugs Research Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
